PACIRA BIOSCIENCES, INC. Stock-Based Compensation
PACIRA BIOSCIENCES, INC. (PCRX) reported Stock-Based Compensation of $28.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $14.96M, a 3.32% decline year-over-year.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $13.54M, a 6.97% decline year-over-year.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.50M, a 10.05% increase year-over-year.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $13.98M, a 5.65% increase year-over-year.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $57.50M, a 12.37% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $51.17M, a 6.84% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $47.90M, a 0.41% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $48.09M, a 13.84% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $28.50M 10-Q · filed 2026-08-04 | $42.00M derived: sum of 3 quarters · filed 2026-08-04 | $55.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $13.54M 10-Q · filed 2026-04-30 | $27.04M derived: sum of 2 quarters · filed 2026-04-30 | $41.02M derived: sum of 3 quarters · filed 2026-04-30 | $56.49M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.48M derived: sum of 2 quarters · filed 2026-02-26 | $42.95M derived: sum of 3 quarters · filed 2026-08-04 | $57.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $13.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $29.45M derived: sum of 2 quarters · filed 2026-08-04 | $44.00M 10-Q · filed 2025-11-06 | $56.27M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $15.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $30.02M 10-Q · filed 2026-08-04 | $42.29M derived: sum of 3 quarters · filed 2026-08-04 | $55.52M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $14.55M 10-Q · filed 2026-04-30 | $26.82M derived: sum of 2 quarters · filed 2026-04-30 | $40.05M derived: sum of 3 quarters · filed 2026-04-30 | $52.57M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $12.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.50M derived: sum of 2 quarters · filed 2026-02-26 | $38.02M derived: sum of 3 quarters · filed 2026-02-26 | $51.17M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $25.75M derived: sum of 2 quarters · filed 2025-11-06 | $38.91M 10-Q · filed 2025-11-06 | $51.33M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $12.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $25.68M 10-Q · filed 2025-08-05 | $38.09M derived: sum of 3 quarters · filed 2026-02-26 | $50.63M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $13.15M 10-Q · filed 2025-05-08 | $25.57M derived: sum of 2 quarters · filed 2026-02-26 | $38.10M derived: sum of 3 quarters · filed 2026-02-26 | $49.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $12.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $24.95M derived: sum of 2 quarters · filed 2026-02-26 | $35.91M derived: sum of 3 quarters · filed 2026-02-26 | $47.90M 10-K · filed 2026-02-26 |
| 2023-09-30 | $12.53M 10-Q · filed 2023-11-02 | $23.48M derived: sum of 2 quarters · filed 2023-11-02 | $35.48M 10-Q · filed 2024-11-06 | $48.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $10.96M 10-Q · filed 2023-08-02 | $22.95M 10-Q · filed 2024-07-30 | $35.62M derived: sum of 3 quarters · filed 2025-02-27 | $48.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $11.99M 10-Q · filed 2024-05-07 | $24.67M derived: sum of 2 quarters · filed 2025-02-27 | $37.35M derived: sum of 3 quarters · filed 2025-02-27 | $48.89M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $12.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $25.36M derived: sum of 2 quarters · filed 2025-02-27 | $36.90M derived: sum of 3 quarters · filed 2025-02-27 | $48.09M 10-K · filed 2025-02-27 |
| 2022-09-30 | $12.68M 10-Q · filed 2023-11-02 | $24.23M derived: sum of 2 quarters · filed 2023-11-02 | $35.41M 10-Q · filed 2023-11-02 | $46.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $11.54M 10-Q · filed 2023-08-02 | $22.73M 10-Q · filed 2023-08-02 | $33.62M derived: sum of 3 quarters · filed 2024-02-29 | $44.41M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $11.19M 10-Q · filed 2023-05-03 | $22.08M derived: sum of 2 quarters · filed 2024-02-29 | $32.86M derived: sum of 3 quarters · filed 2024-02-29 | $43.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $10.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $21.67M derived: sum of 2 quarters · filed 2024-02-29 | $32.13M derived: sum of 3 quarters · filed 2024-02-29 | $42.25M 10-K · filed 2024-02-29 |
| 2021-09-30 | $10.78M 10-Q · filed 2022-11-03 | $21.25M derived: sum of 2 quarters · filed 2022-11-03 | $31.36M 10-Q · filed 2022-11-03 | $42.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $10.46M 10-Q · filed 2022-08-03 | $20.57M 10-Q · filed 2022-08-03 | $31.47M derived: sum of 3 quarters · filed 2023-02-28 | $42.42M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $10.11M 10-Q · filed 2022-05-04 | $21.01M derived: sum of 2 quarters · filed 2023-02-28 | $31.96M derived: sum of 3 quarters · filed 2023-02-28 | $41.18M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $21.85M derived: sum of 2 quarters · filed 2023-02-28 | $31.07M derived: sum of 3 quarters · filed 2023-02-28 | $39.92M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.95M 10-Q · filed 2021-11-03 | $20.18M derived: sum of 2 quarters · filed 2021-11-03 | $29.02M 10-Q · filed 2021-11-03 | $38.21M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $9.22M 10-Q · filed 2021-08-03 | $18.07M 10-Q · filed 2021-08-03 | $27.26M derived: sum of 3 quarters · filed 2022-02-28 | $36.50M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $8.85M 10-Q · filed 2021-05-04 | $18.04M derived: sum of 2 quarters · filed 2022-02-28 | $27.28M derived: sum of 3 quarters · filed 2022-02-28 | $35.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $9.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $18.43M derived: sum of 2 quarters · filed 2022-02-28 | $26.22M derived: sum of 3 quarters · filed 2022-02-28 | $33.65M 10-K · filed 2022-02-28 |
| 2019-09-30 | $9.24M 10-Q · filed 2020-10-30 | $17.03M derived: sum of 2 quarters · filed 2020-10-30 | $24.46M 10-Q · filed 2020-10-30 | $32.65M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $7.78M 10-Q · filed 2020-08-06 | $15.22M 10-Q · filed 2020-08-06 | $23.40M derived: sum of 3 quarters · filed 2021-03-01 | $31.51M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $7.43M 10-Q · filed 2020-05-07 | $15.62M derived: sum of 2 quarters · filed 2021-03-01 | $23.73M derived: sum of 3 quarters · filed 2021-03-01 | $30.77M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $16.29M derived: sum of 2 quarters · filed 2021-03-01 | $23.34M derived: sum of 3 quarters · filed 2021-03-01 | $31.73M 10-K · filed 2021-03-01 |
| 2018-09-30 | $8.11M 10-Q · filed 2019-11-08 | $15.15M derived: sum of 2 quarters · filed 2019-11-08 | $23.54M 10-Q · filed 2019-11-08 | $31.73M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $7.05M 10-Q · filed 2019-08-08 | $15.43M 10-Q · filed 2019-08-08 | $23.63M derived: sum of 3 quarters · filed 2020-02-21 | $32.29M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $8.38M 10-Q · filed 2019-05-02 | $16.58M derived: sum of 2 quarters · filed 2020-02-21 | $25.24M derived: sum of 3 quarters · filed 2020-02-21 | $32.59M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $16.86M derived: sum of 2 quarters · filed 2020-02-21 | $24.20M derived: sum of 3 quarters · filed 2020-02-21 | $31.60M 10-K · filed 2020-02-21 |
| 2017-09-30 | $8.66M 10-Q · filed 2018-11-01 | $16.01M derived: sum of 2 quarters · filed 2018-11-01 | $23.41M 10-Q · filed 2018-11-01 | $31.14M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $7.34M 10-Q · filed 2018-08-02 | $14.74M 10-Q · filed 2018-08-02 | $22.48M derived: sum of 3 quarters · filed 2019-02-28 | $29.84M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $7.40M 10-Q · filed 2018-05-03 | $15.13M derived: sum of 2 quarters · filed 2019-02-28 | $22.49M derived: sum of 3 quarters · filed 2019-02-28 | $30.16M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $15.09M derived: sum of 2 quarters · filed 2019-02-28 | $22.76M derived: sum of 3 quarters · filed 2019-02-28 | $31.25M 10-K · filed 2019-02-28 |
| 2016-09-30 | $7.36M 10-Q · filed 2017-11-08 | $15.03M derived: sum of 2 quarters · filed 2017-11-08 | $23.52M 10-Q · filed 2017-11-08 | $33.24M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $7.67M 10-Q · filed 2017-08-02 | $16.16M 10-Q · filed 2017-08-02 | $25.88M derived: sum of 3 quarters · filed 2018-02-28 | $34.71M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $8.49M 10-Q · filed 2017-05-04 | $18.22M derived: sum of 2 quarters · filed 2018-02-28 | $27.04M derived: sum of 3 quarters · filed 2018-02-28 | $34.34M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $9.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $18.55M derived: sum of 2 quarters · filed 2018-02-28 | $25.85M derived: sum of 3 quarters · filed 2018-02-28 | $33.37M 10-K · filed 2018-02-28 |
| 2015-09-30 | $8.83M 10-Q · filed 2016-11-02 | $16.12M derived: sum of 2 quarters · filed 2016-11-02 | $23.64M 10-Q · filed 2016-11-02 | $48.46M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $7.30M 10-Q · filed 2016-08-04 | $14.81M 10-Q · filed 2016-08-04 | $39.63M derived: sum of 3 quarters · filed 2017-03-01 | $47.32M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $7.52M 10-Q · filed 2016-05-02 | $32.34M derived: sum of 2 quarters · filed 2017-03-01 | $40.02M derived: sum of 3 quarters · filed 2017-03-01 | $45.56M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $24.82M 10-K · filed 2017-03-01 | $32.51M derived: sum of 2 quarters · filed 2017-03-01 | $38.05M derived: sum of 3 quarters · filed 2017-03-01 | $24.82M 10-K · filed 2016-02-25 |
| 2014-09-30 | $7.69M 10-Q · filed 2015-10-27 | $13.22M derived: sum of 2 quarters · filed 2015-10-27 | $17.20M 10-Q · filed 2015-10-27 | $20.48M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $5.54M 10-Q · filed 2015-07-30 | $9.51M 10-Q · filed 2015-07-30 | $12.80M derived: sum of 3 quarters · filed 2016-02-25 | $16.57M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $3.98M 10-Q · filed 2015-04-30 | $7.26M derived: sum of 2 quarters · filed 2016-02-25 | $11.04M derived: sum of 3 quarters · filed 2016-02-25 | $13.26M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $7.06M derived: sum of 2 quarters · filed 2016-02-25 | $9.29M derived: sum of 3 quarters · filed 2016-02-25 | $11.51M 10-K · filed 2016-02-25 |
| 2013-09-30 | $3.78M 10-Q · filed 2014-10-30 | $6.00M derived: sum of 2 quarters · filed 2014-10-30 | $8.23M 10-Q · filed 2014-10-30 | $9.78M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $4.45M 10-Q · filed 2014-07-31 | $6.01M derived: sum of 3 quarters · filed 2015-02-24 | $7.47M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $2.23M 10-Q · filed 2014-05-01 | $3.78M derived: sum of 2 quarters · filed 2015-02-24 | $5.25M derived: sum of 3 quarters · filed 2015-02-24 | $6.29M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.02M derived: sum of 2 quarters · filed 2015-02-24 | $4.06M derived: sum of 3 quarters · filed 2015-02-24 | $4.78M 10-K · filed 2015-02-24 |
| 2012-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $2.51M derived: sum of 2 quarters · filed 2013-10-31 | $3.22M 10-Q · filed 2013-10-31 | $3.75M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.75M 10-Q · filed 2013-08-06 | $2.28M derived: sum of 3 quarters · filed 2014-02-25 | $2.72M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $712.00K 10-Q · filed 2013-05-08 | $1.24M derived: sum of 2 quarters · filed 2014-02-25 | $1.68M derived: sum of 3 quarters · filed 2014-02-25 | $2.23M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $970.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.52M derived: sum of 3 quarters · filed 2014-02-25 | $2.49M 10-K · filed 2014-02-25 |
| 2011-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $993.00K derived: sum of 2 quarters · filed 2012-11-01 | $1.97M 10-Q · filed 2012-11-01 | $1.97M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $551.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.52M 10-Q · filed 2012-08-09 | $1.53M derived: sum of 3 quarters · filed 2013-03-07 | $1.53M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $972.00K 10-Q · filed 2012-05-09 | $978.00K derived: sum of 2 quarters · filed 2013-03-07 | $984.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $12.00K derived: sum of 2 quarters · filed 2013-03-07 | $23.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $17.00K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $11.00K 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | $524.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |